Urinary incontinence (UI) is a common condition in persons over 65 years of age. In the United States alone, there is a 30% prevalence rate in the community and greater than 50% prevalence in nursing homes.1 Even though prevalence increases with age, UI is never normal and it remains treatable regardless of age.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
FDA grants cretostimogene grenadenorepvec Breakthrough and Fast Track Designations for NMIBC
December 5th 2023The designations, which will expedite the development and regulatory review of cretostimogene grenadenorepvec in this setting, are supported by results from the phase 3 BOND-003 trial.